Literature DB >> 33616445

Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System.

Juan Carlos Collantes1, Victor M Tan1, Huiting Xu1, Melany Ruiz-Urigüen1, Amer Alasadi1, Jingjing Guo1, Hanlin Tao1, Chi Su1, Katarzyna M Tyc2, Tommaso Selmi3, John J Lambourne3, Jennifer A Harbottle3, Jesse Stombaugh3, Jinchuan Xing2, Ceri M Wiggins3, Shengkan Jin1.   

Abstract

Conventional CRISPR approaches for precision genome editing rely on the introduction of DNA double-strand breaks (DSB) and activation of homology-directed repair (HDR), which is inherently genotoxic and inefficient in somatic cells. The development of base editing (BE) systems that edit a target base without requiring generation of DSB or HDR offers an alternative. Here, we describe a novel BE system called Pin-pointTM that recruits a DNA base-modifying enzyme through an RNA aptamer within the gRNA molecule. Pin-point is capable of efficiently modifying base pairs in the human genome with precision and low on-target indel formation. This system can potentially be applied for correcting pathogenic mutations, installing premature stop codons in pathological genes, and introducing other types of genetic changes for basic research and therapeutic development.

Entities:  

Year:  2021        PMID: 33616445      PMCID: PMC7898459          DOI: 10.1089/crispr.2020.0035

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


  46 in total

1.  Correction of a pathogenic gene mutation in human embryos.

Authors:  Hong Ma; Nuria Marti-Gutierrez; Sang-Wook Park; Jun Wu; Yeonmi Lee; Keiichiro Suzuki; Amy Koski; Dongmei Ji; Tomonari Hayama; Riffat Ahmed; Hayley Darby; Crystal Van Dyken; Ying Li; Eunju Kang; A-Reum Park; Daesik Kim; Sang-Tae Kim; Jianhui Gong; Ying Gu; Xun Xu; David Battaglia; Sacha A Krieg; David M Lee; Diana H Wu; Don P Wolf; Stephen B Heitner; Juan Carlos Izpisua Belmonte; Paula Amato; Jin-Soo Kim; Sanjiv Kaul; Shoukhrat Mitalipov
Journal:  Nature       Date:  2017-08-02       Impact factor: 49.962

2.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

3.  CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons.

Authors:  Pierre Billon; Eric E Bryant; Sarah A Joseph; Tarun S Nambiar; Samuel B Hayward; Rodney Rothstein; Alberto Ciccia
Journal:  Mol Cell       Date:  2017-09-07       Impact factor: 17.970

4.  Dual base editor catalyzes both cytosine and adenine base conversions in human cells.

Authors:  Xiaohui Zhang; Biyun Zhu; Liang Chen; Ling Xie; Weishi Yu; Ying Wang; Linxi Li; Shuming Yin; Lei Yang; Handan Hu; Honghui Han; Yongmei Li; Liren Wang; Geng Chen; Xueyun Ma; Hongquan Geng; Wanfeng Huang; Xiufeng Pang; Zuozhen Yang; Yuxuan Wu; Stefan Siwko; Ryo Kurita; Yukio Nakamura; Li Yang; Mingyao Liu; Dali Li
Journal:  Nat Biotechnol       Date:  2020-06-01       Impact factor: 54.908

5.  RNA editing with CRISPR-Cas13.

Authors:  David B T Cox; Jonathan S Gootenberg; Omar O Abudayyeh; Brian Franklin; Max J Kellner; Julia Joung; Feng Zhang
Journal:  Science       Date:  2017-10-25       Impact factor: 47.728

6.  Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning.

Authors:  Mandana Arbab; Max W Shen; Beverly Mok; Christopher Wilson; Żaneta Matuszek; Christopher A Cassa; David R Liu
Journal:  Cell       Date:  2020-06-12       Impact factor: 41.582

7.  CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.

Authors:  Daniel P Dever; Rasmus O Bak; Andreas Reinisch; Joab Camarena; Gabriel Washington; Carmencita E Nicolas; Mara Pavel-Dinu; Nivi Saxena; Alec B Wilkens; Sruthi Mantri; Nobuko Uchida; Ayal Hendel; Anupama Narla; Ravindra Majeti; Kenneth I Weinberg; Matthew H Porteus
Journal:  Nature       Date:  2016-11-07       Impact factor: 49.962

8.  Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds.

Authors:  Jesse G Zalatan; Michael E Lee; Ricardo Almeida; Luke A Gilbert; Evan H Whitehead; Marie La Russa; Jordan C Tsai; Jonathan S Weissman; John E Dueber; Lei S Qi; Wendell A Lim
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

9.  Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9.

Authors:  Peiwu Qin; Mahmut Parlak; Cem Kuscu; Jigar Bandaria; Mustafa Mir; Karol Szlachta; Ritambhara Singh; Xavier Darzacq; Ahmet Yildiz; Mazhar Adli
Journal:  Nat Commun       Date:  2017-03-14       Impact factor: 14.919

10.  Search-and-replace genome editing without double-strand breaks or donor DNA.

Authors:  Andrew V Anzalone; Peyton B Randolph; Jessie R Davis; Alexander A Sousa; Luke W Koblan; Jonathan M Levy; Peter J Chen; Christopher Wilson; Gregory A Newby; Aditya Raguram; David R Liu
Journal:  Nature       Date:  2019-10-21       Impact factor: 69.504

View more
  2 in total

Review 1.  An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.

Authors:  Mina Roueinfar; Hayley N Templeton; Julietta A Sheng; Ka Lok Hong
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

Review 2.  Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.

Authors:  Zachary J Tickner; Michael Farzan
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.